抑制CDK9作为小细胞肺癌的有效治疗方法
L Valdez Capuccino1,2,3, T Kleitke1,2,3, B Szokol4
1University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Cell death & disease
|May 20, 2024
概括
循环素依赖性激酶 (CDK) 9抑制对治疗小细胞肺癌 (SCLC) 有希望,特别是在抗化疗的病例中. 这种方法针对关键蛋白质,诱导癌细胞死亡,并在临床前模型中减少瘤生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 小细胞肺癌 (SCLC) 通常会对标准化疗 (cisplatin, etoposide) 和PD-L1抑制剂产生耐药性.
- 迫切需要有效的替代疗法来克服SCLC患者的治疗耐药性.
研究的目的:
- 评估林依赖激酶 (CDK) 9抑制剂,包括迪纳西克利布和新型抑制剂VC-1在小细胞肺癌中的疗效.
- 研究CDK9抑制的治疗潜力,作为对抗化疗耐性SCLC的策略.
主要方法:
- 在小鼠和人类SCLC细胞系中测试了CDK9抑制剂 (dinaciclib,VC-1).
- 研究了细胞死亡的机制,包括对抗亡蛋白MCL-1和cFLIP的影响.
- 在临床前的SCLC模型 (本土和综合性) 中评估了疗效,并评估了与化疗的协同作用.
主要成果:
- CDK9抑制在各种SCLC细胞系中表现出显著的瘤杀伤活性.
- 抑制CDK9降低了MCL-1和cFLIP水平,诱导了内在的亡.
- 抑制CDK9在抗化疗性SCLC细胞中显示出有效性,并在体内减少瘤生长,改善生存率.
结论:
- CDK9抑制是小细胞肺癌的一个强有力的治疗策略.
- 这种方法对于治疗化疗耐药或耐性SCLC特别有希望.
- 向CDK9为SCLC治疗提供了潜在的新途径,特别是在耐药病例中.
更多相关视频
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
5.6K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K